204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER
Abstract available at the source but not redistributed here. Read at source.
577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES
Abstract available at the source but not redistributed here. Read at source.
551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES
Abstract available at the source but not redistributed here. Read at source.
The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.
Abstract available at the source but not redistributed here. Read at source.
Psilocybin and Obsessive-Compulsive Disorder: Exploring New Therapeutic Horizons.
No abstract availability was recorded for this entry.
Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?
Abstract available at the source but not redistributed here. Read at source.
[Treatment with psychedelics: potential benefits in Parkinson's disease].
Abstract available at the source but not redistributed here. Read at source.
Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization
Abstract available at the source but not redistributed here. Read at source.
The effect of low-dose psilocybin on brain neurotransmission and rat behavior.
Abstract available at the source but not redistributed here. Read at source.
The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?
Abstract available at the source but not redistributed here. Read at source.
BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW
Abstract available at the source but not redistributed here. Read at source.
Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners
Abstract available at the source but not redistributed here. Read at source.
Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies
Abstract available at the source but not redistributed here. Read at source.
Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior
No abstract availability was recorded for this entry.
Psilocybin: From Psychiatric Pariah to Perceived Panacea.
Abstract available at the source but not redistributed here. Read at source.
Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?
Abstract available at the source but not redistributed here. Read at source.
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.
Abstract available at the source but not redistributed here. Read at source.
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.
Abstract available at the source but not redistributed here. Read at source.
Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.
Abstract available at the source but not redistributed here. Read at source.